Brief: Vaxart Receives Notice Of Delisting Or Failure From Nasdaq
31/03/2023 13:35
March 31 (Reuters) - Vaxart Inc VXRT.O :
* VAXART INC - ON MARCH 27 RECEIVED NOTICE OF DELISTING OR
FAILURE
TO SATISFY A CONTINUED LISTING RULE OR STANDARD; TRANSFER OF
LISTING FROM NASDAQ
Further company coverage: VXRT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Vaxart
See all newsBrief: Vaxart Expands Intellectual Property Portfolio With European Patent Protecting Proprietary Norovirus Vaccine Technology
Vaxart Q2 revenue falls on lower government contract income
Brief: Vaxart Q2 Net Income USD -13.494 Million
Brief: Vaxart Enters Cooperation Agreement With Stockholder Group And Announces Board And Corporate Governance Enhancements
Vaxart Q1 revenue more than doubles on government contracts